{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:26:55Z","timestamp":1783038415839,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jviromet.2021.114440","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T20:50:02Z","timestamp":1640292602000},"page":"114440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-550X","authenticated-orcid":false,"given":"Vineet","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena R.","family":"Antunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia","family":"Saleh-Birdjandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan S.","family":"Kumru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pospisil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1448-1998","authenticated-orcid":false,"given":"David B.","family":"Volkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2021.114440_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jviromet.2012.09.011","article-title":"Quantification of measles, mumps and rubella viruses using real-time quantitative TaqMan-based RT-PCR assay","volume":"187","author":"Ammour","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2021.114440_bib0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/1471-2180-13-284","article-title":"Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach","volume":"13","author":"Azizi","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.jviromet.2021.114440_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2021.114440_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41541-018-0080-6","article-title":"VaxArray potency assay for rapid assessment of \u201cpandemic\u201d influenza vaccines","volume":"3","author":"Byrne-Nash","year":"2018","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jviromet.2021.114440_bib0025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2016.03.005","article-title":"Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection","volume":"34","author":"Cardin","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2021.114440_bib0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2018.08.006","article-title":"Biophysical virus particle specific characterization to sharpen the definition of virus stability","volume":"132","author":"Clenet","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jviromet.2021.114440_bib0035","article-title":"ICH Topic Q 5 C Quality of Biotechnological Products: Stability Testing of Biotechnological\/Biological Products","author":"EMEA","year":"1996","journal-title":"EMEA"},{"key":"10.1016\/j.jviromet.2021.114440_bib0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1629259","article-title":"HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory","volume":"8","author":"Grunwitz","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jviromet.2021.114440_bib0045","doi-asserted-by":"crossref","first-page":"15327","DOI":"10.1038\/ncomms15327","article-title":"Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy","volume":"8","author":"Kallert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114440_bib0050","first-page":"1","article-title":"Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries","author":"Kumar","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jviromet.2021.114440_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2021.114440_bib0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jps.24211","article-title":"Characterization of an oncolytic herpes simplex virus drug candidate","volume":"104","author":"Kumru","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jviromet.2021.114440_bib0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1099\/0022-1317-37-1-85","article-title":"A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera","volume":"37","author":"Lehmann-Grube","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2021.114440_bib0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2174\/1389201018666170914123305","article-title":"Characterization of inherent particles and mechanism of thermal stress induced particle formation in HSV-2 viral vaccine candidate","volume":"18","author":"Li","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jviromet.2021.114440_bib0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2021.114440_bib0080","series-title":"Pearson\u2019s Product Moment Correlation, Statistical Tutorials and Software Guides","author":"Lund","year":"2020"},{"key":"10.1016\/j.jviromet.2021.114440_bib0085","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/nar\/30.6.1292","article-title":"Real-time PCR in virology","volume":"30","author":"Mackay","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2021.114440_bib0090","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26\u2013 and modified Vaccinia Ankara\u2013vectored ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jviromet.2021.114440_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biologicals.2011.09.012","article-title":"Real time PCR: a rapid tool for potency estimation of live attenuated camelpox and buffalopox vaccines","volume":"40","author":"Prabhu","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2021.114440_bib0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2021.01.016","article-title":"Stability of lyophilized and spray dried vaccine formulations","volume":"171","author":"Preston","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jviromet.2021.114440_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2008.04.046","article-title":"Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes","volume":"378","author":"Quirin","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2021.114440_bib0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2005.08.013","article-title":"Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq)","volume":"131","author":"Ranheim","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2021.114440_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.jviromet.2021.114440_bib0120","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02229-10","article-title":"Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses","volume":"85","author":"Rodrigo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114440_bib0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jviromet.2004.01.009","article-title":"Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR","volume":"117","author":"Schalk","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2021.114440_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biologicals.2005.01.001","article-title":"Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay","volume":"33","author":"Schalk","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2021.114440_bib0135","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1809960","article-title":"Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer","volume":"9","author":"Schmidt","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jviromet.2021.114440_bib0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4155\/bio-2017-0176","article-title":"Principles of vaccine potency assays","volume":"10","author":"Verch","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jviromet.2021.114440_bib0145","first-page":"1","article-title":"Formulation development and improved stability of a combination measles and rubella live-viral vaccine dried for use in the nanopatch(TM) microneedle delivery system","author":"Wan","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jviromet.2021.114440_bib0150","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1016\/j.vaccine.2005.04.023","article-title":"Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency","volume":"23","author":"Wang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2021.114440_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15a01s8","article-title":"Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage","author":"Welsh","year":"2008","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114440_bib0160","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ymthe.2017.07.012","article-title":"Recombinant LCMV vectors induce protective immunity following homologous and heterologous vaccinations","volume":"25","author":"Wingerath","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jviromet.2021.114440_bib0165","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4161\/hv.34453","article-title":"Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines","volume":"10","author":"Zang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jviromet.2021.114440_bib0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421003797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421003797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:54:48Z","timestamp":1759056888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093421003797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"alternative-id":["S0166093421003797"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114440","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114440"}}